• There were 26,180 cases of cancer reported to the Indiana State Cancer Registry in 1996; however, only 24,317 cases are included in the incidence tables because in situ (except bladder) plus basal and squamous skin cases were excluded, per national convention.
• The top five sites for both sexes combined were breast, lung, prostate, colon and lymphomas, which include Hodgkin’s and non-Hodgkin’s lymphoma.
• Breast cancer, lung cancer, and colon cancer were the most frequent cancers diagnosed in women during 1996; prostate cancer, lung cancer, and colon cancer were the most frequent cancers diagnosed in men in the same time period.
• In 1996, the overall age-adjusted cancer incidence rate in Indiana was 360.8 per 100,000 population.
• In Indiana, males had a significantly higher overall cancer incidence rate than females (414.8 vs. 324.9, respectively).
• Breast cancer (including in situ) was the most frequently diagnosed cancer (4,372 cases).
• Lung cancer was the most frequently diagnosed invasive cancer in Indiana (4,151 cases). The 1996 age-adjusted lung cancer incidence rate was 63.0 (87.8 for males, 44.4 for females). Only Marion County had a significantly higher rate (79.9). Allen County had a significantly lower rate (48.8).
• Only Marion County (403.7) had an age-adjusted cancer incidence rate significantly higher than the state rate (360.8) for all sites combined. Brown, Hamilton and Wells Counties had significantly lower rates.
• In 1996, the female breast cancer age-adjusted incidence rate was 102.6 per 100,000. No county had a significantly higher or lower rate.
• The cervical cancer age-adjusted incidence rate was 8.0 per 100,000 population. No county had a significantly higher or lower rate.
• In 1996, the colon cancer age-adjusted incidence rate in Indiana was 31.3 (37.0 for male, 27.3 for female). No county had a significantly higher or lower rate.
• The prostate cancer age-adjusted incidence rate was 98.9 per 100,000 population. Lake County had a significantly higher rate (137.2).
• Blacks had a significantly higher rate than whites for colon and prostate cancer, as well as for all sites combined.

Return to Main Document

Table of Contents